Navigation Links
Lower detection of prostate cancer with PSA screening in US than in a European randomized trial
Date:2/8/2010

Fewer prostate cancers were detected by prostate-specific antigen (PSA) screening in the U.S. than in a European randomized trial because of lower screening sensitivity, according to a new brief communication published online February 8 in the Journal of the National Cancer Institute.

To compare the PSA screening performance in a clinical trial with that in a population setting, Elisabeth M. Wever, MSc, Department of Public Health, Erasmus Medical Center, the Netherlands, and colleagues applied a microsimulation model developed for prostate cancer and screening to the European Randomized Study of Screening for Prostate Cancer (ERSPC)Rotterdam. The model was adapted by replacing the trial's demography parameters with U.S.-specific ones and the screening protocol with the frequency of PSA tests in the population. The natural progression of prostate cancer and the sensitivity (percentage of men correctly identified as having prostate cancer of those who have preclinical prostate cancer) of a PSA test followed by a biopsy were assumed to be the same in the US as in the trial.

The prostate cancer incidence predicted by the model in the U.S. was substantially higher than the actual prostate cancer incidence. However, the actual incidence was reproduced by assuming a substantially lower PSA test sensitivity in the U.S. than in ERSPCRotterdam.

The authors concluded that the efficacy of PSA screening in the U.S. was lower than in ERSPCRotterdam because of the lower sensitivity of PSA testing followed by biopsy. The estimates of PSA test sensitivity were 0.26 in the U.S. versus 0.94 in ERSPCRotterdam.

In an accompanying editorial, Peter C. Albertsen, M.D., of the University of Connecticut Health Center, in Farmington, calls the study's findings remarkable and instructive. If the U.S. ever wanted to match the trial's results, he writes, the intensity of PSA screening and prostate biopsy would need to increase by well more than 50% from the values recorded in 1992, a time when incidence rates were at their peak.

Also, the rates of radical prostatectomy and radiation therapy among men aged 55-69 years would need to increase by 50% to achieve the mortality reduction noted in the ERSPC trial. "The consequences of such large increases in surgery and radiation are sobering," he writes.


'/>"/>

Contact: Steve Graff
jncimedia@oxfordjournals.org
301-841-1285
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. Family meals, adequate sleep and limited TV may lower childhood obesity
2. Risk of stroke lower for recent Ontario immigrants: study
3. Immigrants at Lower Stroke Risk Than Long-Term Residents?
4. Consumer Reports Health: Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist
5. Study Finds Ponseti Method of Clubfoot Correction Leads to Lower Surgical Rates and Less Revision Surgery
6. Mortality rates for pediatric rheumatology patients significantly lower than previously reported
7. News brief: Childhood survivors of CNS cancers and leukemia have lowered educational attainment
8. One Type A Trait May Actually Lower Work Stress
9. For Lower Blood Pressure, Low-Carb Diet May Be Best
10. Fast food menus with calorie information lead to lower calorie selections for young children
11. Research Indicates Participants in Incentive-Based Health Promotion Programs Have Lower Healthcare Costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... , ... May 06, 2016 , ... ... and David Konur, CEO of Cardiovascular Institute of the South announced today that ... performing a live case of an Intravascular Ultrasound Guided Coronary Atherectomy. ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... performance in the industry’s gold standard KLAS Performance Report, Epic Consulting ... report assessed organizations that specialize in consulting services for electronic health record (EHR) ...
(Date:5/5/2016)... ... May 05, 2016 , ... Florida Hospital ... non-valvular atrial fibrillation (A-Fib) an alternative to long-term warfarin medication with the newly ... in April of 2015, Florida Hospital Pepin Heart Institute doctors successfully implanted the ...
(Date:5/5/2016)... , ... May 05, 2016 ... ... hands-on exercises, the Wharton Seminars for Business Journalists , led by ... of key business and economic issues.  This one-day program at the Wharton ...
(Date:5/5/2016)... ... May 05, 2016 , ... An essential tool for researching ... certain Canadian provinces is now available from the International Association of Industrial Accident ... The report, Workers’ Compensation Laws as of January 1, 2016, is ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK ... technology, today announced Food and Drug Administration (FDA) ... defibrillator that provides heart failure patients with access ... devices also have remote monitoring with daily automatic ... the heart rate in response to physiological demands. ...
(Date:5/3/2016)... May 3, 2016   BIOTRONIK will be ... care beyond the implant at the Heart Rhythm Society,s ... San Francisco . ... highest quality of patient care and satisfaction possible. Part ... each and every tomorrow," said Marlou Janssen , ...
(Date:5/3/2016)... 3, 2016 Pharmaceutical giant Johnson ... to a woman who says its talc-based powder products ... Gloria Ristesund $5 million in compensatory damages and ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , This is ... company. In February, the same court awarded $72 million ...
Breaking Medicine Technology: